title: [Treatment of ischemic heart disease in the elderly. Comparison of diltiazem, verapamil and gallopamil].
abstract: The medical therapy of myocardial ischemia in elderly patients has not been well evaluated. We studied the age-related changes in 127 patients with proved coronary artery disease and stable effort angina the efficacy and the safety of diltiazem 120 mg tid, verapamil 120 mg tid and gallopamil 50 mg tid a medium term parallel, double blind cross-over placebo controlled study. All patients have been clinically and ergometrically evaluated. In middle-age patients diltiazem, verapamil and gallopamil induced a significant increasing of exercise duration and time to onset ST segment depression > or = 1 mm. In the elderly patients both verapamil and diltiazem as increased the exercise duration and ischemic threshold, while the diltiazem did not increased the exercise duration even if the time of onset ST segment depression > or = 1 mm is increased. At peak exercise the ST segment depression have been reduced both in middle-age and elderly patients after active drugs. Weekly angina and DNT consumption have been significantly reduced after diltiazem, verapamil and gallopamil in middle-age and elderly patients. Side effects have not been relevant even if gallopamil as a lower frequency of them in comparison to diltiazem and verapamil. No patients stopped the treatment because major side effects. Our experience suggests that diltiazem, verapamil and gallopamil have a similar efficacy and rare well tolerated. The choice of one instead of another must be suggested on the basis of side effects developing.
authors.affiliation: IRCCS Sanatrix, Pozzilli Isernia.
authors.forename: P
authors.initials: P
authors.lastname: Simonelli
authors.forename: A
authors.initials: A
authors.lastname: Papa
authors.forename: B
authors.initials: B
authors.lastname: Macciocchi
authors.forename: F
authors.initials: F
authors.lastname: Auriemma
authors.forename: A
authors.initials: A
authors.lastname: Vetrano
authors.forename: M
authors.initials: M
authors.lastname: Scaletta Romeo di Santillo
authors.forename: A
authors.initials: A
authors.lastname: Ceriello
mesh_terms: D000367:Age Factors; D000368:Aged; D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D017023:Coronary Angiography; D003327:Coronary Disease / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D004110:Diltiazem / Q000627:therapeutic use*; D004341:Drug Evaluation; D005080:Exercise Test; D005260:Female; D005711:Gallopamil / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D005711:Gallopamil; D014700:Verapamil; D004110:Diltiazem
vernacular_title: La terapia della cardiopatia ischemica nell'anziano. Confronto diltiazem, verapamil e gallopamil.